"/> Invitrogen™ Peptide synthétique West Nile Virus Co… | B-LABO France

Invitrogen™ Peptide synthétique West Nile Virus Core Antigen

Réf. : BL-RE-175542Réf. fabricant : 15246439 50 μg
137,00 € HT

Synthetic Peptide

Espèces
Virus
Méthode de purification
purified
Nom usuel
West Nile Virus Core Antigen
Concentration
200 μg/mL
Contenu et stockage
-20°C
Marque
Invitrogen

West Nile Virus Core Synthetic Peptide, PEP-0221, from Invitrogen.

West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins which play a major role for WNV entry into target cells. The viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway as delivery of core gene delivery into the striatum of mouse brain and skeletal muscle resulted in cell death and inflammation.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-175542
Réf. fabricant15246439
EspècesVirus
Méthode de purificationpurified
Nom usuelWest Nile Virus Core Antigen
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.